0001062993-24-008309.txt : 20240411
0001062993-24-008309.hdr.sgml : 20240411
20240411173453
ACCESSION NUMBER: 0001062993-24-008309
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240409
FILED AS OF DATE: 20240411
DATE AS OF CHANGE: 20240411
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Grant Richard N. Jr.
CENTRAL INDEX KEY: 0001821315
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36117
FILM NUMBER: 24839498
MAIL ADDRESS:
STREET 1: C/O INTEST CORP
STREET 2: 804 EAST GATE DR, SUITE 200
CITY: MT. LAUREL
STATE: NJ
ZIP: 08054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTEST CORP
CENTRAL INDEX KEY: 0001036262
STANDARD INDUSTRIAL CLASSIFICATION: INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS [3825]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 222370659
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 804 EAST GATE DR., SUITE 200
CITY: MT. LAUREL
STATE: NJ
ZIP: 08054
BUSINESS PHONE: 856-505-8800
MAIL ADDRESS:
STREET 1: 804 EAST GATE DR., SUITE 200
CITY: MT. LAUREL
STATE: NJ
ZIP: 08054
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2024-04-09
0001036262
INTEST CORP
INTT
0001821315
Grant Richard N. Jr.
C/O INTEST CORP
804 EAST GATE DR, SUITE 200
MT. LAUREL
NJ
08054
1
1
0
0
President & CEO
1
Common Stock
2024-04-09
4
S
0
20000
12.8
D
215217
D
Common Stock
2024-04-10
4
S
0
22000
12.03
D
193217
D
Common Stock
2024-04-11
4
S
0
21500
12.03
D
171717
D
Employee Stock Option (right to buy)
11.33
2034-03-05
Common Stock
30536
30536
D
Employee Stock Option (right to buy)
16.06
2033-03-07
Common Stock
16988
16988
D
Employee Stock Option (right to buy)
9.76
2032-03-08
Common Stock
25692
25692
D
Employee Stock Option (right to buy)
10.62
2031-03-09
Common Stock
112000
112000
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2023.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.46 to $13.23, inclusive. Mr. Grant undertakes to provide inTEST Corporation, any security holder of inTEST Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.83 to $12.56, inclusive. Mr. Grant undertakes to provide inTEST Corporation, any security holder of inTEST Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.91 to $12.20, inclusive. Mr. Grant undertakes to provide inTEST Corporation, any security holder of inTEST Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
This option vests in four equal annual installments commencing on March 6, 2025.
This option vests in four equal annual installments commencing on March 8, 2024.
This option vests in four equal annual installments commencing on March 9, 2023.
This option vests in four equal annual installments commencing on March 10, 2022.
/s/ Richard N. Grant, Jr.
2024-04-11